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Summary 
Peripheral gila help ensure that motor and sensory ax- 
ons are bathed in the appropriate ionic and biochemi- 
cal environment. In Drosophila, peripheral gila help 
shield these axons against the high K ÷ concentration 
of the hemolymph, which would largely abolish their 
excitability. Here, we describe the molecular genetic 
analysis of gliotactin, a novel transmembrane protein 
that is transiently expressed on peripheral gila and that 
is required for the formation of the peripheral blood- 
nerve barrier. In gliotactin mutant embryos, the pe- 
ripheral gila develop normally in many respects, ex- 
cept that ultrastructurally and physiologically they do 
not form a complete blood-nerve barrier. As a result, 
peripheral motor axons are exposed to the high K + 
hemolymph, action potentials fail to propagate, and 
the embryos are nearly paralyzed. 
Introduction 
Gila play a diverse set of roles during the development 
and functioning of the nervous system. During develop- 
ment, they provide cues to help guide migrating cells and 
growth cones, and they secrete a variety of cytokines and 
growth factors that help control the patterning of neuronal 
differentiation. Throughout life, they wrap and insulate ax- 
ons and help establish and maintain the blood-brain bar- 
rier in the central nervous system (CNS) and the blood- 
nerve barrier in the periphery. 
In vertebrates, much is known about the reciprocal inter- 
actions between Schwann cells and the peripheral motor 
and sensory axons. For example, contact with axons stim- 
ulates Schwann cell proliferation and triggers Schwann 
cells either to ensheath and myelinate single large axons 
or to ensheath multiple small (unmyelinated) axons. In trig- 
gering myelin formation, axonal contact also results in the 
induction of many myelin-specific genes (reviewed by 
Doyle and Colman, 1993; Lemke, 1993). A number of my- 
elin-specific proteins that are important for the structure 
of myelin have been isolated. Abnormal nervous system 
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function results from mutations in several of these myelin 
genes, including shiverer and myelin deficient, which are 
disruptions in myelin basic protein (MBP), jimpyand rump- 
shaker, disruptions in PLP, and trembler, a disruption in 
PMP22 (reviewed by Lemke, 1993). Toxin ablation of my- 
elinating Schwann cells also results in demyelination and 
peripheral neuropathy (Messing et al., 1992). Therefore, 
disruption of the glial sheath around peripheral axons re- 
sults in loss of nerve function. 
The precise molecular mechanisms controlling the se- 
quential interactions between gila and axons are not yet 
completely understood. Genetic analysis in an organism 
such as Drosophila offers one way to discover novel mole- 
cules that are essential for glial development and function, 
and that, owing to their low abundance or transient expres- 
sion, might have gone undetected in other systems. While 
Drosophila gila do not form myelin, they develop and func- 
tion in a manner analogous to that of gila in higher organ- 
isms. The peripheral gila in Drosophila are similar to verte- 
brate nonmyelinating Schwann cells in their morphology, 
development, and composition. In Drosophila, peripheral 
gila help wrap and insulate peripheral motor and sensory 
axons. One of their roles is to protect these axons from the 
insect hemolymph, which contains a high K ÷ concentration 
that would largely abolish their resting and action poten- 
tials (Treherne and Pichon, 1972; Lane et al., 1975). Loss- 
of-function mutations in any gene that is essential for the 
establishment and maintenance of this peripheral blood- 
nerve barrier should lead to paralysis. 
In this paper, we describe the cloning, characterization, 
and genetic analysis of gliotactin, a novel transmembrane 
protein in Drosophila that is transiently expressed on em- 
bryonic peripheral gila and that plays an essential role in 
the establishment of the blood-nerve barrier. In gliotactin 
mutant embryos, the peripheral gila develop normally in 
terms of their birth, migration, and differentiation, with one 
exception: ultrastructurally and physiologically, they do 
not form a complete blood-nerve barrier. The peripheral 
axons within these nerves are exposed to the high K + hP_~o- 
lymph, and as a result, action potentials fail to propagate. 
Results 
Identification and Cloning of the gliofactin Gene 
This study began with a set of enhancer trap lines in Dro- 
sophila (Kl&mbt and Goodman, 1991; Nose et al,, 1992) 
that have identical staining patterns that primarily label 
many gila associated with the peripheral nervous system 
(PNS), This set includes lines rL82, J29, AE2, and AM72, 
all of which are homozygously viable and are located at 
position 35E1-2, These enhancer trap lines label gila along 
the two major peripheral motor nerves, which are the inter- 
segmental nerve (ISN) and the segmental nerve (SN), one 
of the exit gila, and a number of gila at the midline of 
the CNS, 
Genomic DNA flanking the P elements in lines AE2, 
J29, and rL82 was isolated by using the plasmid rescue 
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technique and was used to isolate a series of overlapping 
genomic and cDNA clones. The largest cDNA clones were 
sequenced and found to contain an open reading frame 
(ORF) of 2868 bp. One clone (AE2-7.41) was used to probe 
a Northern blot of embryonic poly(A) ÷ RNA and hybridized 
to a single -6  kb band. 
Digoxigenin-labeled anti-sense RNA probes were gen- 
erated frQm the cDNA clone AE2-7.41 and were used for 
whole-mount in situ hybridization of staged embryos. The 
mRNA expression pattern (Figure 1) coincides with the 
pattern of 13-galactosidase expression in the original en- 
hancer trap line. RNA is detected in most peripheral glia, 
some exit glia, and in a number of glia at the midline of 
the CNS. Prior to glial expression, there is some epidermal 
staining in broad, diffuse stripes at early stage 12 that 
diminishes. This epidermal staining is not detected in the 
enhancer trap lines. 
The genomic structure of the gliotactin gene is outlined 
in Figure 2A. The transcription unit is divided into at least 
three exons. The size of the gliotactin mRNA detected by 
Northern blot analysis is 2 kb longer than the largest cDNA 
clone. Because no polyadenylation sequence is found in 
any of these cDNA clones, the gliotactin gene must extend 
farther downstream and may include other exons. The 
putative start of translation is located in the second small 
exon (Figure 2A). The precise genomic locations of the 
three P elements was determined by sequencing the ends 
of the plasmid rescue and polymerase chain reaction 
(PCR) clones (Figure 2B). Given the length of the mRNA in 
Northern blot analysis, it is possible that the 5' untranslated 
region of the gene extends farther upstream. 
The gliotactin Gene Encodes a Novel 
Transmembrane Protein 
The gliotactin deduced protein sequence is shown in Fig- 
u re 2C. The ORF predicts a protein of 956 amino acids with 
a molecular weig ht of 109 kDa, The sequence contains two 
neighboring initiation codons followed by a putative signal 
sequence. A potential transmembrane sequence divides 
the protein into a large extracellular domain and a smaller 
intracellular domain. The extracellular domain contains a 
200 amino acid region (Figure 2C) that shows a high de; 
Figure 1. gliotactin RNA Expression 
Whole-mount gliotectin RNA in situ hybridiza- 
tion of a mid-stage 17 embryo that is double 
stained with MAb 1D4. 
(A and B) gliotactin RNA expression in the pe- 
riphery ([A] is focused on muscles 7 and 6, 
while [B] is a more external focal plane [deeper 
relative to the dissection]). The arrows in (A) 
and (13) mark some of the peripheral glia ex- 
pressing gliotactin RNA. 
(C and D) gliotactin RNA in the CNS ([C] is 
focused on the midline glia, while .fD] is a more 
external focal plane). The arrow in (C) marks 
an exit gila expressing RNA; the arrowhead in 
(C) marks the midline glia expressing RNA. 
With the exception of these midline gila, most 
CNS glia do not express gliotactin. The position 
of the intersegmental nerve (ISN) and the seg- 
mental nerve branches aand c (SNa and SNc) 
are indicated. The digoxigenin-labeled RNA 
probes were detected by using alkaline phos- 
phatase and reacted with nitroblue tetrazolium 
(NBT) and 5-bromo-4-chloro-3-indolylphos- 
phate toluidinium (BCIP) (purple reaction prod- 
uct). Embryos were double stained with the 
MAb 1D4 (anti-fasciclin II) using horseradish 
peroxidase (HRP) immunocytochemistry (b own 
reaction product). 
Scale bar, 10 ~m. 
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Figure 2. gliotactin Gene Structure, Mutant Map, and Deduced Amino 
Acid Sequence 
(A) The genomic structure of the gliotactin gene is shown, indicating 
the position of the exons represented in the cDNA clones. The boxes 
correspond to the cDNA sequences, with open boxes indicating un- 
translated sequences and hatched boxes indicating coding se- 
quences. Some restriction enzyme sites are shown, with polyrnorphic 
sites in brackets. The terminal structure of the 3' untranslated end of 
the gene (missing from the cDNA clones) is uncertain (broken outline). 
Below is shown the extent of the deletions in four lethal mutations 
generated by the imprecise excision of the AE2 and J29 P elements. 
(B) The sequence of the gliotactin 5' untranslated region, including the 
analysis of the AE2 deletion mutants, is shown. The data are combined 
from cDNA and genomic clones, with the genomic sequence in lower- 
case and the cDNA sequence in uppercase type. The locations of 
three of the enhancer trap P elements are labeled and indicated by 
open arrows. The extents of the three AE2 deletion mutants are also 
indicated. Two potential transcription initiation sites are highlighted 
that match the Drosophila consensus sequence (Hultmark et al., 1986) 
at six out of seven positions, one of which coincides with the 5' end 
of the longest cDNA clone. 
(C) The gliotactin deduced amino acid sequence. The putative signal 
sequence is underlined, and the transmembrane domain is double 
underlined. The serine esterase-like domain is highlighted with an 
open box (see Figure 3). 
gree of sequence similarity to the serine esterase family of 
proteins. Figu re 3 compares the similar sequences among 
gliotactin, serine esterases, and serine esterase-like pro- 
teins. Many of these proteins are enzymes and contain 
an active serine esterase site, which is indicated by the 
arrow in the underlined region. This site is missing the 
serine residue required for esterase activity in the gliotac- 
tin protein and in the two other Drosophila serine esterase- 
like proteins, neurotactin and glutactin (see Discussion). 
The gliotactin cDNA was expressed in $2 cells to deter- 
mine whether gliotactin is indeed a transmembrane pro- 
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Figure 3. The Serine Esterase-like Domains in Gliotactin and Other 
Related Proteins 
The serine esterase domain from the gliotactin protein is shown 
aligned with similar domains in other proteins. Each sequence is listed 
in order of similarity to gliotactin as determined by the BLAST algorithm 
(National Center for Biotechnology Information). Amino acids found 
in three or more of the six sequences are highlighted. The enzymatic 
site in the active serine esterase enzymes is double underlined, with 
an arrow indicating the position of the essential serine residue. The 
D symbol in the D-ache sequence indicates a deletion of 28 amino 
acids to maximize the alignment. The positions of cysteine residues 
homologous to those involved in disulfide bridges in acetylcholines- 
terase (MacPhee-Quigley et al., 1986) are marked with asterisks. 
H-carbox, human liver carboxylesterase (Long et al., 1991); H-ache, 
human acetylcholinesterase (Soreq et aL, 1990); D-ache, Drosophila 
melanogaster acetylcholinesterase (Hall and Spierer, 1986); glutactin, 
Drosophila glutactin (Olson et al., 1990); neurotactin, Drosophila neu- 
rotactin (Hortsch et al., 1990). 
tein and whether the protein can bind to itself or to some 
endogenous protein expressed on $2 cells. A cDNA con- 
taining the entire ORF was subcloned into an S2 expres- 
sion vector under the control of the metailothionein pro- 
moter (Bunch et al., 1988). Protein expression was 
induced in the transformed $2 ceils. A single protein band 
of approximately 105-110 kDa is recognized on Western 
blots of whole embryo protein probed with anti-gliotactin 
antisera or monoclonal antibody (MAb) 1F6 (see below). 
The same size band is seen on Western blots of membrane 
proteins isolated from induced $2 cells and was not pres- 
ent in uninduced or control $2 cells. The gliotactin- 
expressing $2 cells were tested for cell aggregation. No 
aggregates were seen after 48 hr of induction, whereas 
control $2 cells expressing the homophilic cell adhesion 
molecule fasciclin II (Grenningloh et al., 1990) showed 
robust aggregation. These experiments indicate that glio- 
tactin is a membrane protein that does not appear to bind 
to itself in a homophilic fashion and does not appear to 
bind to any other protein on $2 cells. 
The Gliotactin Protein Is Expressed Almost 
Exclusively on Gila 
Polyclonal antisera and subsequently a MAb (1F6) were 
generated against gliotactin fusion proteins and tested for 
staining of embryonic tissue. The staining patterns of the 
antisera and 1 F6 MAb are essentially identical and corre- 
spond with the RNA in situ pattern. By use of the 1F6 MAb, 
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staining of the peripheral glia is first detected at stage 13 
and becomes steadily stronger throughout later stages. 
At stages 16-17, the entire surface of these glia appears 
to stain. The gliotactin-expressing lia extend from the 
nerve roots just inside the CNS along most of the major 
peripheral nerves, including the ISN up to the main tra- 
cheal trunk and along two SN branches, the SNa and SNc 
(Figure 4C). When compared with the anti-RK2 antibody, 
which stains all known peripheral glia (Campbell et al., 
1994), the gliotactin protein is expressed on all of the glia 
associated with the peripheral motor and sensory nerves; 
it is not expressed, however, on the glia associated with 
sensory structures. 
A pair of glial cells at the midline of the CNS also stain 
strongly at stages 16-17; these cells are also positive in 
the whole-mount RNA in situs. At earlier stages (stages 
12-13), there is some faint staining along the midline that 
is not seen in the in situs. Since this staining is absent in 
mutant embryos, it is likely to represent some small 
amount of authentic gliotactin expression at the midline. 
At early stage 12, there is some diffuse epidermal stain- 
ing that diminishes and is completely absent by stages 
16-17. There is also staining restricted to the trachea at 
stages 13-14 that becomes concentrated to small patches 
on the main tracheal trunks (Figure 4). At later stages, 
there is staining associated with the hindgut. 
In third instar larvae, gliotactin expression is extremely 
weak, even with the most sensitive detection protocols. 
A pair of stained cells are observed at the midline of the 
thoracic ganglia and along the large nerve trunks leaving 
the CNS. There are also faint patches of staining in the 
larval leg and antennal discs, in the trachea, and in the 
PNS. However, the glia enwrapping the peripheral nerves, 
the major location of gliotactin expression in the embryo, 
show little or no protein expression in the larvae. 
Generation and Characterization of Mutations 
in the gliotactin Gene 
To generate mutations in the gliotactin gene, imprecise 
excisions of the P elements in enhancer trap lines J29 
Figure 4. Expression of Gliotactin Protein in 
Wild-Type Embryo and Location of Peripheral 
Gila in gliotactin Mutant Embryo 
Each set of panels (A-C and D-F) shows digital 
composites of two different focal planes, mov- 
ing from the dorsal region of the embryo near 
the main tracheal trunk (T) (A and D) to the 
ventral CNS (C and F). 
(A-C) Wild-type mid-stage 17 embryo stained 
with the anti-gliotactin MAb 1 F6 (brown-black) 
to reveal extent of glial wrappings of gliotactin- 
expressing peripheral glia. The arrow in (A) 
marks end of the glial wrapping ofthe ISN prior 
to its reaching the main tracheal (T) trunk (com- 
pare with brown axon staining in [D]); the arrow 
in (B) marks the end of the glial wrapping of 
the SNa just prior to its bifurcation (compare 
with [E]). The arrow in (C) marks the gliotactin- 
expressing exit gila; the arrowhead marks the 
gliotactin-expressing midline glia (compare 
with Figure 1). The HRP immunoreaction prod- 
uct is enhanced with a silver-gold detection 
system. 
(D-F) gliotactin mutant mid-stage 17 embryo 
(I(2)AE2A4b) stained with anti-RK2 antiserum 
(blue-black) that reveals the location of the nu- 
clei of the peripheral glia and all CNS glia 
(feathered arrow) except the m idline giia, which 
do not stain. The staining of the glial nuclei is 
intensified with nickel. The embryo is double 
stained with MAb 1D4 (anti-fasciclin II) (brown- 
stained axons). The arrow in (D)marks the ex- 
tension of the ISN past the main tracheal (T) 
trunk and into the dorsal muscles, and the 
feathered arrow marks a glial nucleus at a side 
branch of the ISN that does not express gliotac- 
tin. The arrows in (E) mark the bifurcation f the 
SNa in the lateral muscle region. These loca- 
tions of motor axons should be compared with 
the extent of the glial wrapping of the peripheral 
nerves as shown by the arrows marking the 
end of the gliotactin staining in (A)and (B). 
Scale bar, 10 p.m. 
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and AE2 were created by mobilizing these P elements and 
selecting for lethal excisions. These lethal excisions failed 
to complement two overlapping deficiencies, Df(2L)osp29 
and Df(2L)rlO. The set of allelic lethals thus maps to the 
interval spanning 35E1-2 to 35E6. The lethals were 
mapped to a number of lethal complementation groups in 
this region, and all fail to complement three ethyl methane- 
sulfonate (EMS)-induced alleles of a single complementa- 
tion group: 1(2)35Dg P~R77, 1(2)35Dg P29, and 1(2)35Dg P34. 
Four of the lethal excision mutants, 1(2)AE2/145, 
1(2)AE2/14b, 1(2)AE2/I6a, and 1(2)J29/I 7b, as well as a con- 
trol viable excision, AE2A4a, were further characterized 
molecularly by using PCR. Gliotactin-specific oligonucleo- 
tides were used to amplify DNA isolated from heterozy- 
gous mutant adults and homozygous mutant embryos. 
The resulting PCR products were sequenced and ana- 
lyzed. All of the lethal excisions have at least the first exon 
and a part of the first intron deleted (see Figure 2A). Similar 
PCR analysis shows that the viable excision AE2A4a is 
a precise excision. 
These lethal excisions appear to be both mRNA and 
protein null mutations, as indicated by in situ hybridization 
and immunocytochemical analysis. The mutant lines were 
crossed to balancers containing lacZ embryonic markers, 
and homozygous mutant embryos were identified as nega- 
tive for l~-galactosidase expression. Whole-mount in situs 
were carried out on three of the lethal lines, 1(2)AE2A45, 
1(2)AE2/14b, and 1(2)AE2/16a, and on the precise excision 
AE2z14a. All three mutant lines show no detectable RNA 
expression, whereas the viable line is indistinguishable 
from wild type. These same mutant lines show no antibody 
staining, whereas the precise excision line AE2/i4a has 
the same staining pattern and signal intensity as does 
wild type. In addition, the three EMS alleles (1(2)35Dg RAR77, 
1(2)35Dg P29, and 1(2)35Dg ~)  also fail to stain with the anti- 
gliotactin antibody. 
The mutant embryos appear normal in all embryonic 
tissues as assayed by antibody staining (see Experimental 
Procedures). The PNS and CNS appear normal. The num- 
ber and morphology of muscles are normal, and the recto- 
neurons appear to innervate these muscles in the appro- 
priate locations. The trachea of these embryos appear 
normal, except that they do not fill with air toward the end 
of embryogenesis. The peripheral glia have the normal 
number and location, as indicated by staining mutant em- 
bryos with the RK2 antibody (Figure 4), which labels the 
nuclei of all peripheral glia (Campbell et al., 1994). 
The lethal mutations were analyzed to determine the 
time of lethality. Mutant embryos progress normally to very 
late stages and then fail to hatch. The trachea failing to 
fill with air is unlikely to be the cause of late embryonic 
lethality, since embryos can survive for several days in 
the absence of an air-filled tracheal system (Manning and 
Krasnow, 1993). Rather, the mutants appear morphologi- 
cally normal, but the embryos fail to show the characteris- 
tic coordinated peristaltic movements associated with the 
latest stages of embryogenesis. There is some motion de- 
tected in the mutants, but this movement tends to be unco- 
ordinated and rarely extends down the length of the em- 
bryo. A sharp tap with a blunt needle to the head or tail fails 
to elicit any response in the majority of embryos (>90%) in 
mutant lines 1(2)AE2/14b and 1(2)AE2/145 (n -- 84 and n -- 
69, respectively), whereas the viable excision embryos 
always move (>99%; n = 143). Thus, the mutants are 
partially paralyzed. 
Electrophysiological Analysis of gliotactin Mutants 
The normal pattern of movement, missing from the mutant 
embryos, is restored in dissected mutant embryos by re- 
placing the hemolymph with a low K + saline solution. To 
determine the physiological basis for this behavioral de- 
fect, electrophysiological experiments were performed on 
dissected late stage (20-22 hr after egg laying at 25°C) 
mutant (AE2/14b) and control (AE2/14a) embryos. The via- 
ble line is not distinguishable from wild type. 
To monitor changes in the spontaneous activity (Figure 
5), muscle 6 was voltage-clamped at-60 mV and endoge- 
nous synaptic currents recorded over a range of different 
external K ÷ concentrations. At a low K ÷ concentration (2 
mM) in the bathing solution, the mutant embryos display 
normal coordinated activity in muscle 6, similar to that 
seen in control embryos. The muscle physiology, the size 
of synaptic currents, and the patterning of bursts of synap- 
tic activity all appear normal. Each burst underlies a single 
muscle contraction during the normal peristaltic body 
movements occurring during late embryonic movement 
and larval locomotion. 
Changes in the Na ÷, Ca ÷2, or Mg +2 concentrations have 
no differential effect on mutant compared with control em- 
bryos. On the other hand, changes in the K ÷ concentration 
have dramatic effects on mutant embryos compared with 
controls (Figure 5). A 10-fold increase in K ÷ concentration 
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Figure 5. Electrophysiological Analysis of gliotactin Mutant Embryos 
Whole-cell recordings of synaptic urrents in muscle 6 at the end of 
embryogenesis (20-22 hr after egg-laying, equivalent tolate stage 17) 
from the control viable excision AE2/14a (left column) and gliotactin 
mutant 1(2)AE2/14b (right column) embryos. The muscle was voltage- 
clamped at -60 mV and endogenous synaptic urrents recorded in 
a range of external K+ concentrations. The gliotactin mutant shows a 
greatly enhanced sensitivity to external K + concentration. At low K + 
(2 mM) concentrations, the mutant shows relatively normal synaptic 
communication. Atintermediate K ÷ (20 raM) concentrations, the mu- 
tant shows suppressed synaptic activity. At high, physiological levels 
of K ÷ (40 raM), patterned synaptic ommunication is nearly abolished. 
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(20 mM) causes a significant depression in synaptic activ- 
ity in muscle 6 of the mutant embryos; both the duration 
and frequency of motor bursts are greatly reduced. These 
embryos show reduced motor activity, and both the fre- 
quency and coordination of muscle peristalsis are dramati- 
cally impaired. This depression is even more pronounced 
at K ÷ concentrations of 40 raM, which is approximately 
the concentration of K ÷ found in Drosophila hemolymph 
(Ashburner, 1989). Patterned synaptic communication is 
nearly abolished. Synaptic currents are still observed, but 
they no longer occur in patterned, high frequency bursts. 
Coordinated movement is absent. 
To determine whether action potential propagation is 
failing (Figure 6), we stimulated the ISN near the point 
where it exits the CNS and recorded synaptic currents. 
We used the more distal muscle 4 to eliminate passive 
stimulation of the nerve terminal, which is occasionally 
observed in muscle 6. In wild-type embryos, muscle 4 re- 
ceives at least three synaptic inputs that can be clearly 
distinguished in current recordings (Figure 6A). In the con- 
trol embryos, robust transmission in all three axons is 
maintained at both low K ÷ concentrations (2 mM) and high, 
physiological K ÷ concentrations (40 mM). The amplitude 
of these synaptic currents is slightly reduced at high K ÷ 
concentrations, presumably owing to a reduced resting 
potential in the presynaptic terminal, which lacks a protec- 
tive glial covering in the embryo (see below). In gliotactin 
mutant embryos, robust transmission along all three axons 
is maintained at low K ÷ concentrations but is eliminated 
at high K ÷ concentrations. In addition, an increase lag be- 
tween synaptic currents is usually seen in the mutants 
even at low K ÷ levels, suggesting that the rate of conduc- 
tion of the action potential is affected in the mutant even 
in low K ÷ concentrations. 
E lect ron  Mic roscop ic  Ana lys i s  o f  gliotactin Mutants  
Serial section electron micrographs of peripheral nerves 
in mutant embryos (n = 8) and wild type (n = 6, Canton 
S; n = 1, precise excision) at mid-stage 17 were examined 
to look for potential defects in glial ultrastructure or glial 
wrappings around peripheral axons. At this stage, the neu- 
romuscular system is fully functional, including coordi- 
nated synaptic bursts and peristaltic movements (Broadie 
and Bate, 1993). 
In all of the mid-stage 17 wild-type embryos examined, 
the glial wrappings around the peripheral motor axons do 
not extend to the synaptic terminals, but rather terminate 
about 5-10 I~m before the synapses, thus leaving 5-10 
I~m of naked motor axon exposed to the high K ÷ hemo- 
lymph. At this stage, glial wrappings extend out the JSN 
to the main tracheal trunk; out the SNa to before its bifurca- 
tion (just past muscle 12); out the SNb for only a short 
distance after it enters the ventral muscle region; and out 
the SNc. These results mirror the extent and staining pat- 
tern of the peripheral glia observed with the anti-gliotactin 
MAb (see Figure 5). Once the motor axons begin to split 
away from the major motor nerves and extend toward their 
specific muscle targets, they are no longer covered by 
glial wrappings in mid-stage 17 embryos. For instance, 
at mid-stage 17, the motor axons that extend the farthest 
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Figure 6. Elevated Levels of Extracellular K ÷ Preferentially Block Ac- 
tion Potential Conduction in gliotactin Mutant Embryos 
(A) The peripheral motor nerve was stimulated with a suction electrode 
near the point where it exits the CNS, and synaptic currents were 
recorded in voltage-clamped (-60 mV) dorsal longitudinal muscle 4. 
in the control (viable excision line AE2z14a), robust transmission is 
maintained at both low K ÷ (2 mM) and high, physiological K ÷ (40 mM) 
concentrations. In the gliotactin mutant (I(2)AE2A4b), robust ransmis- 
sion is maintained at low K ÷ but eliminated at high K + concentrations. 
An increased lag between synaptic currents is usually seen in the 
mutants even at low K ÷ concentrations. 
(B) The distribution in transmission efficiency in the control and mutant 
at both low and high K ÷ concentrations. A given nerve stimulus gener- 
ates action potential conduction in either all axons innervating muscle 
4 (three axons) or a subset of axons (one to two), or it fails to elicit 
action potentials in any of the axons (zero). In the control, the normal 
response is that all three axons conduct action potentials at both low 
and high K ÷ concentrations, and complete transmission failure is a 
rare event (<10%). In the mutant, successful transmission occurs in 
most axons at low K ÷ levels, but transmission usually fails in all axons 
(>75%) at high K ÷ levels. Each bar represents the mean _+ SD for at 
least ten embryos of each genotype. 
(aCC, the three Us, and RP2 axons in the ISN) are wrapped 
by peripheral gila for about 110-120 I~m of their length 
and then are naked for the last/>10 I~m. This is in contrast 
with third instar larvae, in which the gUa do extend out to 
the synaptic terminals and fully enwrap the motor axons 
(Atwood et al., 1993). We have also observed anti- 
gliotactin antibody staining of nerve terminals on larval 
muscles, further confirming the presence of glial pro- 
cesses at larval nerve terminals. 
We next examined the ultrastructure of the peripheral 
nerves in gliotactin mutant embryos at mid-stage 17. The 
glial cells are in their normal position along the various 
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Figure 7. The Peripheral Glia in gliotactin Mu- 
tant Embryos Do Not Completely Wrap the P - 
ripheral Axons 
Representative electron micrographs of wild- 
type (A and C) and gliotactin mutant (B and D) 
embryos at mid-stage 17 at two positions along 
the intersegmental nerve (ISN), the first just 
distal to the point where the SNb leaves the 
ISN (A and B), and the second 25 p.m distal 
to this position and past the chordotonal axon 
entry point (C and D). The sections shown here 
are representative of the similarities (A com- 
pared with B) and differences (C versus D) ob- 
served in mutant (n = 8,1(2)AE2A 4b allele) ver- 
sus wild-type (n = 6, Canton S; n = 1 AE2A4a 
precise excision) embryos. G, glial cell; T, tra- 
cheal cell; arrowheads, basement membranes 
around cells. 
(A) At the level of a glial cell body in wild type, 
glial processes completely enwrap the axons 
of the ISN. 
(B) At a similar location in the gliotactin mutant, 
glial processes also completely enwrap the ax- 
ons of the ISN and appear wild type. 
(C) At a more distal location between glial cell 
bodies in wild type, glial processes completely 
enwrap the axons of the ISN. 
(D) At a similar location in the gliotactin mutant, 
glial processes do not completely enwrap the 
axons of the ISN, and instead, many axons are 
exposed to the hemolymph (arrow). 
Scale bar, 0.5 p.m. 
nerves and have a relatively normal morphology. Particu- 
larly in regions of the glial cell bodies, the glial processes 
appear to wrap around the axons in a normal fashion (com- 
pare Figure 7A with Figure 7B). However, two differences 
are apparent. First, in wild-type embryos at mid-stage 17, 
the wrappings are complete in the regions of the peripheral 
nerves between the glial cell bodies (Figure 7C), whereas 
in gliotactin mutant embryos at the same stage, the glial 
wrappings are incomplete and have openings and large 
gaps (Figure 7D). Second, toward the ends of the nerves, 
the glial wrappings terminate or become incomplete 
sooner than in wild-type embryos, leaving longer stretches 
of naked motor axons (data not shown). This is most appar- 
ent for the SNb, where in wild-type embryos the glial pro- 
cesses extend and completely enwrap the motor axons 
for 5 t~m or so along the SNb into the ventral muscle region, 
whereas in gliotactin mutant embryos, the SNb axons are 
naked or incompletely wrapped for most of their length. 
These results suggest that in wild type, the glial wrap- 
pings are complete and thus are likely to protect the periph- 
eral axons from the high K ÷ concentration in the hemo- 
lymph. In the gliotactin mutants, on the other hand, the 
wrappings are not complete, leaving gaps and openings 
that allow direct exposure of the axons to the bathing solu- 
tion. To confirm this conclusion independently, we treated 
dissected mutant (n = 3) and wild-type (n = 2) mid-stage 
17 embryos to fixatives containing 1.5-3.0 mg/ml ruthe- 
nium red (see Experimental Procedures) (Figure 8). Ruthe- 
nium red is a highly charged, electron-dense cation of low 
molecular weight and size (786 Da; diameter 1.13 nm) that 
binds to polyanionic macromolecules uch as heparin and 
condroitin sulfate in basement membranes, in extracellu- 
lar matrix, and on cell surfaces (Luft, 1971a, 1971b). Ru- 
thenium red does not cross cell membranes and when 
applied exogenously without detergent is an excellent ex- 
tracellular tracer for electron microscopy (EM). 
In wild-type embryos, ruthenium red is seen around the 
outside and between some of the glial wrappings, but none 
completely penetrates the glial junctions around the axons 
and none is found around the axons themselves (Figures 
8A and 8C). In contrast, in gliotactin mutant embryos 
treated in the same way, ruthenium red enters the periph- 
eral nerves and is seen decorating the membranes of the 
axons (Figures 8B and 8D). 
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Figure 8. Penetration of Ruthenium Red around 
Peripheral Nerve Axons in gliotactin Mutant 
Embryos 
Representative electron micrographs of wild- 
type (A and C) and gliotacrin mutant (B and D) 
embryos at mid-stage 17 at two positions along 
the ISN just distal to the point where the SNb 
leaves the ISN (A and B), and along the SNa 
just prior to its bifurcation past muscle 12 (C 
and D). In contrast with the conventional EM 
shown in Figure 7, these embryos were stained 
with ruthenium red, an electron-dense extracel- 
lular tracer (see t xt for details). The sections 
shown here are representative of the similar- 
ities (A compared with B) and differences (C 
versus D) observed in mutant (n = 3, 
/(2)AE2/14b allele) versus wild-type (n = 2, 
Canton S) embryos. G, glial cell; T, tracheal 
cell; arrowheads, ruthenium red staining of 
basement membranes around cells. 
(A) In wild type, ruthenium red stains the out- 
side of the nerve and the area between some 
glial processes (arrow), but does not penetrate 
the inner glial junctions and thus does not stain 
the membranes of the axons in the ISN. 
(B) At a similar location in the gliotactin mutant, 
ruthenium red fully penetrates the nerve and 
stains the membranes of the axons in the ISN 
(arrow). 
(C) The SNa in wild type is similar to the ISN 
in that ruthenium red stains the surfaces of the 
gila (arrow) but does not penetrate the inner 
glial junctions and thus does not stain the mem- 
branes of the axons. 
(D) In contrast, in the gliotactin mutant, the ax- 
ons in the SNa re stained by ruthenium red 
(arrow). 
Scale bar, 0.5 p.m. 
Discussion 
In this paper, we describe the cloning, characterization, 
and genetic analysis of gliotactin, a novel transmembrane 
protein that plays an essential role in the establishment 
of the peripheral blood-nerve barrier in Drosophila. Glio- 
tactin is transiently expressed on the surface of the periph- 
eral glia that wrap the peripheral motor and sensory axons 
in the embryo and on at least some midline glia in the CNS. 
The gliotactin protein has a putative signal sequence, a 
transmembrane domain, and a cytoplasmic domain with 
no obvious similarity to other known proteins. The gliotac- 
tin protein also contains an extracellular domain with se- 
quence similarity to members of the serine esterase fam- 
ily. The serine esterase domain is likely to be a structural 
motif only, as the serine residue essential for enzymatic 
activity is missing in the gliotactin protein and in two other 
Drosophila serine esterase-l ike proteins, neurotactin and 
glutactin. Glutactin is a secreted protein found in base- 
ment membranes (Olson et al., 1990). Neurotactin is a 
transmembrane protein expressed in the nervous system 
(Hortsch et al., 1990); neurotactin is found at sites of cel l -  
cell contact and can mediate heterophilic ell aggregation 
(Barthalay et al., 1990). Thus, gliotactin belongs to a family 
that includes members that appear to mediate cell-cell 
and cel l -matrix interactions during development. 
One of the functions of the gliotactin-expressing periph- 
eral glia in Drosophila is to help ensure that motor and 
sensory axons are protected for most of their length from 
the high K ÷ hemolymph that would otherwise abolish their 
excitability and lead to paralysis. In wild-type embryos, the 
gliotactin-expressing peripheral glia do their job. At the 
ultrastructural level, these glia completely enwrap the pe- 
ripheral axons for much of their length. Moreover, ruthe- 
nium red, a small electron-dense extracellular tracer, does 
not penetrate the peripheral nerves to stain the axons in 
wild-type embryos. 
In gliotactin mutant embryos, however, the peripheral 
glia fail at this crucial job. At the light microscope level, 
the peripheral glia in the mutant embryos appear normal 
in their number, location, and morphology. However, 
these glia do not form a complete peripheral blood-nerve 
barrier, resulting in major physiological and behavioral def- 
icits. The gliotactin mutant embryos are partially para- 
lyzed, show no coordinated peristaltic movements, and 
fail to hatch. When bathed in a high K + solution (40 mM), 
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gliotactin mutants physiologically show very little motor 
activity, and action potentials fail to propagate in the pe- 
ripheral motor nerves. These deficits can be rescued by 
bathing the dissected embryos in a low K ÷ solution (2 mM). 
These results confirm that the sensory and motor systems 
are properly wired and can function normally in the mutant 
embryos. Immunohistochemistry with various antibodies 
indicates that the structure of the PNS is normal. Ultra- 
structurally, the peripheral nerves in the mutant embryos 
show gaps and openings in their glial wrappings; more- 
over, the gila allow small molecules such as ruthenium 
red to penetrate the nerves freely and bathe the axons. 
Thus, the absence of gliotactin protein leads to a failure 
to form a peripheral blood-nerve barrier. As a result, the 
peripheral motor and sensory axons are exposed to a high 
K ÷ extracellular environment, and this in turn leads to the 
behavioral and physiological defects observed in the mu- 
tants. Such a conclusion is consistent with previous results 
from a variety of organisms, showing that exposure of ax- 
ons to high K ÷ leads to blockage of excitability and to paral- 
ysis (Grossman et al., 1979; Kocsis et al., 1983). 
One surprise arising from our electron microscopic ex- 
amination of wild-type embryos is that in mid-stage 17 
embryos, the glial wrappings around the peripheral motor 
axons do not extend all of the way out to the synaptic 
terminals, but rather terminate about 5-10 pm before the 
synapses, thus leaving 5-10 p,m of naked motor axon ex- 
posed to the high K ÷ hemolymph. This is in contrast with 
third instar larvae, in which the gila do extend out to the 
synaptic terminals and fully enwrap the motor axons (At- 
wood et al., 1993). While it is difficult to determine the 
exact consequence of 5-10 p,m of naked motor axon on 
the magnitude of the action potential, it seems likely that 
the action potential is passively conducted for this final 
short stretch. In the absence of measurements of the mem- 
brane capacitance and core and membrane resistance of 
these embryonic axons, it is impossible to calculate the 
appropriate space constants of these axons accurately. 
Using numbers for resistances obtained from mammals 
and squid, we determined that the space constant for 
these axons (0.1-0.2 I~m diameter) ranges from 60 to 180 
pm. Such estimates are in agreement with what we infer 
from the wild-type versus the mutant physiology. Evi- 
dently, the wild-type embryonic axons can maintain their 
excitability when exposed to high K ÷ hemolymph for their 
final 5-10 p.m of length. In contrast, in the g/iotactin mu- 
tant, exposure of these axons to the high K ÷ hemolymph 
for large portions of their 50-120 t~m length leads to either 
an intermittent or complete block in the propagation of 
action potentials. This is presumably due to the decrement 
in the passively conducted potentials along the stretches 
exposed to high K ÷. In larvae, peripheral nerves are often 
many millimeters in length, and thus the glial wrappings 
need to extend for the entire length of the peripheral 
nerves. 
How does gliotactin control the establishment of the pe- 
ripheral blood-nerve barrier in Drosophila? The protein 
probably does not function as a major glial adhesion mole- 
cule. The protein does not mediate aggregation of 
transfected $2 cells. The protein is only transiently ex- 
pressed while the glia are forming the peripheral blood- 
nerve barrier, but once this process is complete, the pro- 
tein largely disappears and is barely detectable in larvae. 
In regions of glial cell bodies, the glial wrappings appear 
normal even in the absence of gliotactin expression. 
Rather, it is in the region where neighboring glial pro- 
cesses should form a complete glial sheath around the 
axons that we detect openings and gaps in the gliotactin 
mutant. Therefore, we suggest that gliotactin functions in 
some sort of cell-cell interaction mechanism to ensure 
that neighboring gila completely enwrap the peripheral 
axons. It seems plausible that such a necessary interac- 
tion could either be glial-glial or glial-axonal. Thus, the 
present model leads to the prediction that either peripheral 
glia or peripheral axons express a ligand that binds to 
gliotactin and induces the processes from neighboring 
glial cells to enwrap the peripheral axons completely. It 
is likely that the molecular machinery controlling these 
events has counterparts erving similar functions in other 
organisms, and thus, that gliotactin-like molecules may 
be required for the formation of the blood-nerve barrier 
in mammals as well. 
Experimental Procedures 
DNA Techniques 
Standard molecular biology methods were used (Maniatis et al., 1982). 
Genomic DNAs flanking the enhancer trap P elements were isolated 
by using the plasmid rescue technique. The largest plasmid rescue 
clone, a region of 4 kb flanking the AE2 P element (AE2Sstl), was 
used to screen the Kolodkin ~.DASH genomic library and the Zinn 
Zgtl 1 cDNA library (Zinn et al., 1988). The clones obtained all mapped 
to position 35E1-2 and cross-reacted with the plasmid rescue clones 
obtained from the other P element lines. Four independent cDNA 
clones (ranging from 3 to 4 kb) were sequenced by the dideoxy method. 
In Situ Hybridization 
Digoxigenin-labeled antisense or sense RNA probes were made from 
the largest cDNA clone, AE2-7.41. These probes were generated for 
whole-mount insitu hybridization offixed embryos as described pre- 
viously (Kopczynski and Muskavitch, 1892), with minor modifications 
(C. Kopczynski). The treated embryos were antibody stained as de- 
scribed below. 
Generation of Antibodies 
Bacterial trpE fusion genes were constructed in the pATH vectors 
(Koerner et al., 1991) by using a number of fragments from the giiotac- 
tin cDNA AE2-7.41. The only fusion to produce a significant immune 
response contained the last 70 amino acids of the protein coding se- 
quence (Pstl[2841]-Clal fragment). After induction, fusion protein was 
extracted from purified inclusion bodies. Mice were injected with ap- 
proximately 50-100 p.g of protein emulsified in adjuvant. After a num- 
ber of rounds of injections, a positive response was detected, and 
spleen lymphocytes from one mouse were fused to myeloma cells to 
generate MAb-producing clones. Clones were tested by both enzyme- 
linked immunosorbent assay and immunostaining of fixed embryos. 
One clone was isolated (1F6) and subcloned that showed a strong 
response similar to that of the polyclonal antisera. 
Cell Culture Experiments 
$2 cells (Schneider, 1972) were grown and selected as described 
previously (Grenningloh et al., 1990). $2 cells were transformed by 
use of the lipofectin reagent (Bethesda Research Laboratories), with 
the following plasmids: pMHA3, containing the AE2-7.41 cDNA under 
the control of the methallothionein promoter (Bunch et al., 1988), and 
pPC4 to confer ~-amanitin resistance as the selectabte marker. Cells 
from 10 ml cultures were pelleted, rinsed in serum-free Schneider's 
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media, and then induced in the presence of 0.7 mM CuSO4 in serum- 
free media for 24 hr at room temperature. 
Generation and Analysis of Mutations 
The enhancer trap P elements (P[w*,/acZ]) of lines AE2 and J29 were 
mobilized by crossing to flies carrying a stable source of transposase, 
the P[ry +, 42-3] chromosome (Robertson et al., 1988). For each en- 
hancer trap, a set of lethal excisions was isolated that failed to comple- 
ment the lethals from the other P element excisions, failed to comple- 
ment the deficiencies Df(2L) osp29, Adh[uf3], pr, cn/CyO and Df(2L)rl O, 
cn//n(2LR)O, I, dp[/v/], pr, on[2], and failed to complement alleles of 
/(2)35Dg (/(2)35Dg ~R77, 1(2)35Dg ~, and/(2)35Dg ~) (provided by M. 
Ashburner). Mutant chromosomes were placed over marked balancer 
chromosomes carrying lacZ markers: CyO, P[elav-lacZ] and CyO, 
P[acUn-lacZ]. All subsequent antibody staining was carried out on 
mutant embryos that had been previously stained with X-Gal. 
PCR was carried out (Saiki et al., 1988) by using gliotactin-specific 
oligonucleotides and DNA isolated from mutant and control ines. DNA 
was isolated from heterozygous mutant adults and homozygous mu- 
tant embryos. Although the DNA from adults was a mixture of wild 
type (balancer) and mutant, the smaller PCR products corresponding 
to the mutant deletions were easily identifiable. For the viable excision, 
AE2A4a, DNA was obtained from homozygous adults. The PCR prod- 
ucts obtained from the AE2A45, AE2,d4b, and AE2A4a excision lines 
were sequenced. 
Antibody and I~-Galactosidase Staining 
Immunohistochemistry and X-Gal staining were carried out as de- 
scribed previously (Patel et al., 1987; Kl&mbt et al., 1991). The PNS 
was analyzed by staining with the MAbs 1 D4 (anti-fasciclin II) (G. Helt 
and C. S. G., unpublished data) and 22C10 (Fujita et al., 1982). The 
CNS was assayed with MAb BP102 (A. Bieber, N. Patel, and C. S. G., 
unpublished data) and MAb 1D4. Muscles were stained with anti- 
myosin MAb (gift of D. P. Kiehart); trachea was stained with anti- 
crumbs MAb (-repass and Knust, 1993); and gila were stained using 
MAb 1F6 (anti-gliotactin) and anti-RK2 (Campbell et al., 1994). 
~-Galactosidase in embryos was detected by using X-Gal staining as 
described previously (Kl&mbt et al., 1991) but minus the Triton X-100. 
The stained embryos were cleared in glycerol (in phosphate-buffered 
saline), dissected, and photographed. 
Electrophysiology 
Embryos were collected and staged from timed egg lays. Mutants were 
placed over marked balancers or out-crossed to Oregon R (both yield 
the same results). Staged embryos were dissected as reported earlier 
(Broadie and Bate, 1993) and physiological recordings performed on 
a single identified neuromuscular junction on muscle 6 (a ventral ongi- 
tudinal muscle) or a set of junctions on muscle 4 (a dorsal longitudinal 
muscle) (Bate, 1990) in abdominal segments A2-A3. Whole-cell cur- 
rent recordings from embryonic and larval muscles were made with 
patch pipettes with resistances of 3-5 megohms by using standard 
patch-clamp techniques as reported earlier (Broadie and Bate, 1993). 
The muscle was voltage-clamped at -60 inV. Signals were amplified 
by using an Axonpatch-1D (Axon Instruments) patch-clamp amplifier 
and filtered with an 8-pole Bessel filter at 2 kHz. Data were analyzed 
with PCLAMP 5.51 software (Axon Instruments). For stimulation exper- 
iments, the motor nerve was stimulated with a suction electrode near 
the point where it exits the CNS (Broadie and Bate, 1993). Recordings 
were performed in fly saline. The standard bath consisted of the follow- 
ing (in millimoles per liter): 140 NaCI, 2 KCI, 4 MgCI2, 1.8 CaCI2, 4 
NaHCO3, 5 N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid 
(TES), 5 trehalose, 36 sucrose. The K ÷ concentration of this standard 
bath was modified as indicated. The intracellular solution consisted 
of the following (in millimoles per liter): 120 KCI, 20 KOH, 4 MgCI2, 5 
TES, 5 EGTA, 0.25 CaCI2, 4 ATP, 0.4 GTP, 5 trehalose, 36 sucrose. 
The pH of all solutions was buffered at 7.15. 
Identifying Individual gliotactin Mutant Embryos for EM 
To identify gliotactin mutant embryos collected from an 1(2)AE2A4b/ 
CyO# stock (13 = J~-actin), eggs were screened with the fluorescent 
LS-galactosidase substrate fluorescein digalactoside (FDG; Molecular 
Probes, Incorporated) as follows. Embryos for conventional EM were 
dechorionated and fixed for 10 rain in heptane previously equilibrated 
with an equal volu me of 50% glutaraldehyde and 10% acrolein in 100 
mM sodium cacodylate buffer (pH 7.4). These embryos were then 
rinsed with heptane, transferred to sodium cacodylate buffer, and man- 
ually devitellinized. Embryos for ruthenium red staining were manually 
devitellinized and opened. The fixation was gentler: 1-2 rain in a solu- 
tion of lO/o glutaraldehyde in 100 mM sodium cacodylate buffer (pH 
7.4). After fixation, the embryos were rinsed with sodium cacodylate 
buffer. The fixed embryos were incubated for 15 min on ice with 1 mM 
FDG in 100 mM sodium cacodylate buffer (pH 7.4), rinsed with sodium 
cacodylate buffer, and examined at room temperature for fluorescein 
isothiocyanate fluorescence. Nonfluorescent embryos (AE2A4b ho- 
mozygous, and Canton S or AE2A4a controls) were processed as 
described below. 
Conventional EM 
Embryos collected and screened as described above were fixed for an 
additional 2 hr with 2% glutareldehyde in 100 mM sodium cacodylate 
buffer (pH 7.4), rinsed in buffer, and posffixed with 1O/o OsO4 in 100 
mM sodium cacodylate buffer. Posffixed embryos were rinsed with 
buffer followed by distilled water and then stained en bloc with 1% 
aqueous uranyl acetate. After staining, the embryos were rinsed with 
water, dehydrated in an ethanol series followed by propylene oxide, 
and embedded in Eponate 12 resin. Serial 100 nm sections were cut, 
picked up on Formvar film-coated slot grids, and stained with uranyl 
acetate followed by Sato's lead (Sato, 1968). Sections were photo- 
graphed with a JEOL 1200EX/II electron microscope. 
Ruthenium Red Staining 
Embryos collected and screened as described above were fixed for 
an additional 1-2 hr with 2% glutaraldehyde in 100 mM sodium caco- 
dylate buffer (pH 7.4) to which 1.5-3.0 mg/ml of ruthenium red (Aldrich 
Chemical Company) was added. Following fixation, the embryos were 
rinsed in buffer containing ruthenium red and postfixed with lO/o OsO4 
in sodium cacodylate buffer containing ruthenium red. Postfixed em- 
bryos were rinsed in buffer without ruthenium red and were further 
processed for EM as described above, except they were not en bloc 
stained with uranyl acetate following postfixation. 
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